CA Patent

CA2561829A1 — Crystal of 1,2-dihydropyridine compound and method for producing same

Assigned to Eisai R&D Management Co Ltd · Expires 2006-01-12 · 20y expired

What this patent protects

Disclosed are a crystal of 3-(2-cyanophenyl)-5- (2-pyridyl)-1-phenyl-1,2-dihydropyridine-2-one and a method for producing the same.

USPTO Abstract

Disclosed are a crystal of 3-(2-cyanophenyl)-5- (2-pyridyl)-1-phenyl-1,2-dihydropyridine-2-one and a method for producing the same.

Drugs covered by this patent

Patent Metadata

Patent number
CA2561829A1
Jurisdiction
CA
Classification
—
Expires
2006-01-12
Drug substance claim
No
Drug product claim
No
Assignee
Eisai R&D Management Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.